Periosteum tissue engineering in an orthotopic in vivo platform
- 1 March 2017
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 121, 193-204
Abstract
No abstract availableKeywords
Funding Information
- ANZ Trustees (CT 22770)
- Australian Research Council
- NHMRC (1082313)
- German Research Foundation (DFG HO 5068/1-1, DFG WA 3606/1-1)
- National Breast Cancer Foundation (NBCF IN-15-047)
- Australian Research Council (FT110101117)
- Worldwide Cancer Research (WWCR 15-11563)
- Australian Government
This publication has 48 references indexed in Scilit:
- TGFβ signaling plays a critical role in promoting alternative macrophage activationBMC Immunology, 2012
- Mesenchymal Stem Cells Secrete Multiple Cytokines That Promote Angiogenesis and Have Contrasting Effects on Chemotaxis and ApoptosisPLOS ONE, 2012
- Brief Review of Models of Ectopic Bone FormationStem Cells and Development, 2012
- Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healingInjury, 2011
- Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury modelJournal of Bone and Mineral Research, 2011
- Vimentin Inhibits ATF4-mediated Osteocalcin Transcription and Osteoblast DifferentiationJournal of Biological Chemistry, 2009
- A Perspective: Engineering Periosteum for Structural Bone Graft HealingClinical Orthopaedics and Related Research, 2008
- Bone marrow–derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculatureBlood, 2008
- Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodiesProceedings of the National Academy of Sciences, 2007
- Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heartDevelopment, 2003